ADVERTISEMENT

Duterte to Duque: Answer allegations on delay in Pfizer vaccine acquisition

Published Dec 17, 2020 02:54 pm

President Duterte told Health Secretary Francisco Duque III to answer allegations that he was to blame for the delay in the country's acquisition of Pfizer's COVID-19 vaccine.

Presidential spokesman Harry Roque made the statement after Senator Panfilo Lacson, citing Foreign Affairs Secretary Teodoro Locsin Jr. and Philippine Ambassador to the United States Jose Manuel Romualdez, revealed that it was Duque who “dropped the ball” on the Philippines' chance to acquire 10 million doses of Pfizer's vaccine, reportedly set for delivery as early as next month.

President Rodrigo Roa Duterte holds a meeting with some members of the Inter-Agency Task Force on the Emerging Infectious Diseases (IATF-EID) at the Malago Clubhouse in Malacañang on April 8, 2020.
(TOTO LOZANO/PRESIDENTIAL PHOTO / MANILA BULLETIN)

Lacson quoted Romualdez as saying that Duque failed to prepare documentary requirement for the government to be able to buy the vaccines.

This document is called confidentiality disclosure agreement, said Lacson. Romualdez, Lacson said, had talks with Secretary of State Mike Pompeo and Locsin, on the Pfizer vaccine issue since last July.

In his Thursday presser, Roque said that he brought up the issue with Duterte during their meeting in Malacañang on Wednesday evening where Duque had the chance to explain himself to the President.

“Minabuti ni Presidente Duterte na advise-an si (President Duterte opted to advise) Secretary Duque answer the allegations of Secretary Locsin in the same manner that he defended himself in yesterday's meeting,” he said.

“Very lively, animated, and emotional po ang pagsagot ni Secretary Duque kagabi (Secretary Duque was very lively, animated, and emotional when he was explaining to the President). The President asked him answer it the same way he discussed the issues. So, antayin na lang po natin ang mga kasagutan ni Secretary Duque (let's just wait for Secretary Duque's response),” he added.

No Pfizer promise – Duque

But in an interview with CNN Philippines Thursday, Duque said there was no promise from Pfizer that it will provide the Philippines with 10 million doses of its COVID19 vaccine next month.

Duque said the US-based pharmaceutical company did not give a “definitive” number of vaccine supply for the Philippines in their previous discussions.

“Walang ganon (There was no promise). It was all indicative numbers, there was no definitive supply because…in the production of these vaccines as we are talking…meron daw problema sa kanilang raw materials (they are having problems with their raw materials)…there was nothing binding, nothing in our talks so this was all open-ended,” Duque said when asked if Pfizer ever promised to give the Philippines 10 million doses of its vaccine by January.

Despite the allegations against Duque, Roque said President Duterte did not seem to mind the issue.

“I think from the overall demeanor of the President, wala naman po siyang nakikita na major lapse dahil ang pinag-uusapan ay kontrata at hindi naman abogado po si Secretary Duque (he didn't see any major lapse because we're talking about a contract here and Secretary Duque is not a lawyer),” he said.

“Wala naman pong danyos na nangyari because patuloy pa rin po ang pagkuha natin ng Pfizer (No damage has been done because we still have ongoing negotiations with Pfizer),” he added.

Duque vs Locsin

Despite this, Roque said that it does not matter if Duque, Romualdez, and Locsin have conflicting opinions regarding the matter because it is only Vaccine Czar Carlito Galvez Jr. who has the authority to handle the vaccine acquisition.

“Mag-away na ang lahat kung gusto nila (Everyone can fight) but the President has made it clear: There's only one person in charge of getting vaccine, it's Secretary Galvez,” he said.

“These conflicting opinions between Secretary Locsin and Secretary Duque, in the end, do not really matter because it's Secretary Galvez who has full authority and he will be fully accountable to the President, no one else,” he added.

Roque likewise expressed confidence that Galvez will not botch the country's vaccine deal with pharmaceutical companies.

“Given the track record of Secretary Galvez, I think that's a far shot. We will succeed because of the proven competence of Secretary Galvez,” he said.

According to Roque, the country can still have the Pfizer vaccine between the second to the third quarter of next year because talks with Pfizer are in the advanced stage.

However, he could not discuss other details because of a nondisclosure agreement (NDA).

“ NDA applies to the volume, applies to the cost, and applies to the delivery date. Please understand I can't respond even if I knew,” he said.

“But, on purpose, dahil si Secretary Galvez naman ang incharge diyan, hindi ko na po 'yan pinanghihimasukan (I will not get into that since Secretary Galvez is the one in-charge),” he added. (With reports from Mario B. Casayuran and Noreen Jazul)

ADVERTISEMENT
.most-popular .layout-ratio{ padding-bottom: 79.13%; } @media (min-width: 768px) and (max-width: 1024px) { .widget-title { font-size: 15px !important; } }

{{ articles_filter_1561_widget.title }}

.most-popular .layout-ratio{ padding-bottom: 79.13%; } @media (min-width: 768px) and (max-width: 1024px) { .widget-title { font-size: 15px !important; } }

{{ articles_filter_1562_widget.title }}

.most-popular .layout-ratio{ padding-bottom: 79.13%; } @media (min-width: 768px) and (max-width: 1024px) { .widget-title { font-size: 15px !important; } }

{{ articles_filter_1563_widget.title }}

{{ articles_filter_1564_widget.title }}

.mb-article-details { position: relative; } .mb-article-details .article-body-preview, .mb-article-details .article-body-summary{ font-size: 17px; line-height: 30px; font-family: "Libre Caslon Text", serif; color: #000; } .mb-article-details .article-body-preview iframe , .mb-article-details .article-body-summary iframe{ width: 100%; margin: auto; } .read-more-background { background: linear-gradient(180deg, color(display-p3 1.000 1.000 1.000 / 0) 13.75%, color(display-p3 1.000 1.000 1.000 / 0.8) 30.79%, color(display-p3 1.000 1.000 1.000) 72.5%); position: absolute; height: 200px; width: 100%; bottom: 0; display: flex; justify-content: center; align-items: center; padding: 0; } .read-more-background a{ color: #000; } .read-more-btn { padding: 17px 45px; font-family: Inter; font-weight: 700; font-size: 18px; line-height: 16px; text-align: center; vertical-align: middle; border: 1px solid black; background-color: white; } .hidden { display: none; }
function initializeAllSwipers() { // Get all hidden inputs with cms_article_id document.querySelectorAll('[id^="cms_article_id_"]').forEach(function (input) { const cmsArticleId = input.value; const articleSelector = '#article-' + cmsArticleId + ' .body_images'; const swiperElement = document.querySelector(articleSelector); if (swiperElement && !swiperElement.classList.contains('swiper-initialized')) { new Swiper(articleSelector, { loop: true, pagination: false, navigation: { nextEl: '#article-' + cmsArticleId + ' .swiper-button-next', prevEl: '#article-' + cmsArticleId + ' .swiper-button-prev', }, }); } }); } setTimeout(initializeAllSwipers, 3000); const intersectionObserver = new IntersectionObserver( (entries) => { entries.forEach((entry) => { if (entry.isIntersecting) { const newUrl = entry.target.getAttribute("data-url"); if (newUrl) { history.pushState(null, null, newUrl); let article = entry.target; // Extract metadata const author = article.querySelector('.author-section').textContent.replace('By', '').trim(); const section = article.querySelector('.section-info ').textContent.replace(' ', ' '); const title = article.querySelector('.article-title h1').textContent; // Parse URL for Chartbeat path format const parsedUrl = new URL(newUrl, window.location.origin); const cleanUrl = parsedUrl.host + parsedUrl.pathname; // Update Chartbeat configuration if (typeof window._sf_async_config !== 'undefined') { window._sf_async_config.path = cleanUrl; window._sf_async_config.sections = section; window._sf_async_config.authors = author; } // Track virtual page view with Chartbeat if (typeof pSUPERFLY !== 'undefined' && typeof pSUPERFLY.virtualPage === 'function') { try { pSUPERFLY.virtualPage({ path: cleanUrl, title: title, sections: section, authors: author }); } catch (error) { console.error('ping error', error); } } // Optional: Update document title if (title && title !== document.title) { document.title = title; } } } }); }, { threshold: 0.1 } ); function showArticleBody(button) { const article = button.closest("article"); const summary = article.querySelector(".article-body-summary"); const body = article.querySelector(".article-body-preview"); const readMoreSection = article.querySelector(".read-more-background"); // Hide summary and read-more section summary.style.display = "none"; readMoreSection.style.display = "none"; // Show the full article body body.classList.remove("hidden"); } document.addEventListener("DOMContentLoaded", () => { let loadCount = 0; // Track how many times articles are loaded const offset = [1, 2, 3, 4, 5, 6, 7, 8, 9, 10]; // Offset values const currentUrl = window.location.pathname.substring(1); let isLoading = false; // Prevent multiple calls if (!currentUrl) { console.log("Current URL is invalid."); return; } const sentinel = document.getElementById("load-more-sentinel"); if (!sentinel) { console.log("Sentinel element not found."); return; } function isSentinelVisible() { const rect = sentinel.getBoundingClientRect(); return ( rect.top < window.innerHeight && rect.bottom >= 0 ); } function onScroll() { if (isLoading) return; if (isSentinelVisible()) { if (loadCount >= offset.length) { console.log("Maximum load attempts reached."); window.removeEventListener("scroll", onScroll); return; } isLoading = true; const currentOffset = offset[loadCount]; window.loadMoreItems().then(() => { let article = document.querySelector('#widget_1690 > div:nth-last-of-type(2) article'); intersectionObserver.observe(article) loadCount++; }).catch(error => { console.error("Error loading more items:", error); }).finally(() => { isLoading = false; }); } } window.addEventListener("scroll", onScroll); });

Sign up by email to receive news.